Pharmaceutical innovation between scientific opportunities and economic constraints

New drugs are only developed when sales expectations appear to match the rising expenditures for development. The repertoire of diseases that are seriously addressed by large pharmaceutical companies is shrinking. Genomics offers the promise of inventing and developing more selective therapies for a...

Full description

Bibliographic Details

Published in:	Drug discovery today Vol. 2; no. 9; pp. 365 - 372
Main Authors:	Drews, Jürgen, Ryser, Stefan
Format:	Journal Article
Language:	English
Published:	Oxford Elsevier Ltd 01-09-1997 Elsevier Science
Subjects:	Biological and medical sciences General pharmacology Medical sciences Miscellaneous Pharmacology. Drug treatments Drug Costs Choice Constraint Health economy Genetics Pharmaceutical industry Research and development
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!